Growth Metrics

Usana Health Sciences (USNA) Other Accumulated Expenses (2016 - 2026)

Usana Health Sciences has reported Other Accumulated Expenses over the past 16 years, most recently at $87.0 million for Q2 2026.

  • Quarterly Other Accumulated Expenses fell 13.35% to $87.0 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $87.0 million through Apr 2026, down 13.35% year-over-year, with the annual reading at $97.3 million for FY2026, 7.01% down from the prior year.
  • Other Accumulated Expenses was $87.0 million for Q2 2026 at Usana Health Sciences, down from $97.3 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $147.3 million in Q1 2022 and troughed at $87.0 million in Q2 2026.
  • The 5-year median for Other Accumulated Expenses is $104.6 million (2023), against an average of $110.8 million.
  • Year-over-year, Other Accumulated Expenses decreased 19.95% in 2022 and then grew 6.66% in 2025.
  • A 5-year view of Other Accumulated Expenses shows it stood at $132.8 million in 2022, then decreased by 18.67% to $108.0 million in 2023, then dropped by 3.1% to $104.6 million in 2024, then dropped by 2.1% to $102.4 million in 2025, then decreased by 15.07% to $87.0 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Other Accumulated Expenses are $87.0 million (Q2 2026), $97.3 million (Q1 2026), and $102.4 million (Q3 2025).